Sadahira T, Maruyama Y, Hiyama Y, Kitano H, Yamada H, Goto T, Kondo T, Shigemura K, Mitsui Y, Iwata T, Edamura K, Araki M, Watanabe M, Takenaka T, Teishima J, Miyata Y, Ishikawa K, Takaoka EI, Miyazaki J, Takahashi S, Masumori N, Kiyota H, Fujisawa M, Yamamoto S, Sakuma T, Kusumi N, Ichikawa T, Watanabe T, Nasu Y, Tsugawa M, Nasu Y, Wada K: A Clinical Trial Evaluating the Usefulness of Tailored Antimicrobial Prophylaxis Using Rectal-culture Screening Media Prior to Transrectal Prostate Biopsy: A Multicenter, Randomized Controlled Trial. Acta Med Okayama. 75(5); 663-667: 2021
Wada K, Yokoyama T, Uno S, Araki M, Sadahira T, Maruyama Y, Acosta H, Nakajima H, Hiyama Y, Kunishima Y, Togo Y, Nukaya T, Yamada H, Shigemura K, Ito S, Tanimura M, Kobayashi K, Kitano H, Teishima J, Yasuda M, Uehara S, Hamasuna R, Watanabe T, Nakagawa T, Hayami H, Miyazaki J, Takahashi S, Masumori N, Ishikawa K, Kiyota H, Fujisawa M, Arakawa S, Nasu Y, Yamamoto S: Nationwide surveillance of bacterial pathogens isolated from patients with acute uncomplicated cystitis in 2018: Conducted by the Japanese Research Group for Urinary Tract Infections (JRGU). J Infect Chemother. 27(8); 1169-1180: 2021
Takahashi S, Arakawa S, Ishikawa K, Kamei J, Kobayashi K, Shigemura K, Takahashi S, Hiyama Y, Hamasuna R, Hayami H, Yazawa S, Yasuda M, Togo Y, Yamamoto S, Wada K, Watanabe T: Guidelines for Infection Control in the Urological Field, including Urinary Tract Management (revised second edition). Int J Urol. 28(12); 1198-1211: 2021
Matsuda Y, Kobayashi K, Fukuta F, Takayanagi A, Hashimoto K, Tanaka T, Masumori N : Which Happens Earlier, Lower Urinary Tract Symptoms or Erectile Dysfunction? Sex Med. 9 (2); 100275.
doi: 10.1016/j.esxm.2020.10.003: 2021
Okada M, Kobayashi K, Fukuta F, Hashimoto K, Tanaka T, Masumori N: What sexual symptoms are most related to testosterone deficiency among older Japanese men? Int J Urol. 28 (12); 1306-1307: 2021
小林 皇：性機能からみた前立腺癌、Urological Surgery Hokkaido、2021年11月18日、Web
腫瘍
【論文】
Matsuki M, Hirohashi Y, Nakatsugawa M, Murai A, Kubo T, Hashimoto S, Tokita S, Murata K, Kanaseki T, Tsukahara T, Nishida S, Tanaka T, Kitamura H, Masumori N, Torigoe T: Tumor-infiltrating CD8+ T cells recognize a heterogeneously expressed functional neoantigen in clear cell renal cell carcinoma. Cancer Immunol Immunother. doi: 10.1007/s00262-021-03048-6: 2021
Sakai Y, Shindo T, Sato S, Takahashi A, Kunishima Y, Kato R, Itoh N, Okada M, Tachiki H, Taguchi K, Takayanagi A, Hotta H, Horita H, Matsukawa M, Matsuki M, Nishiyama K, Miyazaki A, Hashimoto K, Tanaka T, Masumori N: Antiresorptive agent related osteonecrosis of the jaw (ARONJ) in urological
malignancies: a multi center retrospective study. J Bone Miner Metab. 39(4); 661-667: 2021
Shindo T, Hashimoto K, Tanaka T, Taguchi K, Takahashi A, Itoh N, Okada M, Hotta H, Kunishima Y, Hirose T, Matsukawa M, Tachiki H, Kato R, Hinotsu S, Masumori N: Therapeutic options to reduce intravesical recurrence in newly diagnosed Ta high-grade bladder cancer according to risk stratification: A multicenter retrospective study. Int J Urol. 28(11); 1136-1142.doi: 10.1111/iju.14657: 2021
Tamura K, Osawa T, Takeuchi A, Minami K, Nakai Y, Ueda K, Ozawa M, Uemura M, Sugimoto M, Ohba K, Suzuki T, Anai S, Shindo T, Kusakabe N, Komiyama M, Tanaka K, Yokomizo A, Kohei N, Shinohara N, Miyake H: Japanese Urological Oncology Group. External validation of the albumin, C-reactive protein and lactate dehydrogenase model in patients with metastatic renal cell carcinoma receiving second-line axitinib therapy in a Japanese multi-center cohort. Jpn J Clin Oncol. 51(5); 810-818: 2021
Yokomizo A, Koga H, Ito K, Takezawa Y, Komiyama M, Nishimura K, Yonese J, Hashine K, Masumori N, Arai G, Saito S, Shinohara M, Shimizu N, Yamauchi A, Satoh T, Tochigi T, Kobayashi M, Fujimoto H, Kakimoto K, Fukui I, Tsukamoto T, Nozaki M, Karasawa K, Hasumi M, Ohtani M, Ishiyama H, Kuwahara M, Harada M, Ohashi Y, Kotake T, Kakizoe T, Suzuki K, Naito S, Yamanaka H, National Research Project on Endocrine-Radiation Combination Therapy for Locally Advanced Prostate Cancer investigators：Patient-reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/ intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial. Cancer Med. 10(10); 3240-3248: 2021
Shibamori K, Hashimoto K, Shindo T, Tabata H, Kyoda Y, Kobayashi K, Tanaka T, Masumori N: Outcomes of open partial nephrectomy for renal cell carcinoma in the minimally invasive approach era. Curr Urol. 15; 198-203: 2021
Shiota M, Terada N, Saito T, Yokomizo A, Kohei N, Goto T, Kawamura S, Hashimoto Y, Takahashi A, Kimura T, Tabata KI, Tomida R, Hashimoto K, Sakurai T, Shimazui T, Sakamoto S, Kamiyama M, Tanaka N, Mitsuzuka K, Kato T, Narita S, Yasumoto H, Teraoka S, Kato M, Osawa T, Nagumo Y, Matsumoto H, Enokida H, Sugiyama T, Kuroiwa K, Inoue T, Mizowaki T, Kamoto T, Kojima T, Kitamura H, Sugimoto M, Nishiyama H, Eto M; Japanese Urological Oncology Group (JUOG): Differential prognostic factors in low- and high-burden de novo metastatic hormone-sensitive prostate cancer patients. Cancer Sci. 112(4); 1524-1533: 2021
Uemura H, Masumori N, Takahashi S, Hosono M, Kinuya S, Sunaya T, Horio T, Okayama Y, Kakehi Y: Real-world safety and effectiveness of radium-223 in Japanese patients with castration-resistant prostate cancer (CRPC) and bone metastasis: exploratory analysis, based on the results of post-marketing surveillance, according to prior chemotherapy status and in patients without concomitant use of second-generation androgen-receptor axis-targeted agents. Int J Clin Oncol. 26(4); 753-763: 2021
Shiota M, Terada N, Kitamura H, Kojima T, Saito T, Yokomizo A, Kohei N, Goto T, Kawamura S, Hashimoto Y, Takahashi A, Kimura T, Tabata KI, Tomida R, Hashimoto K, Sakurai T, Shimazui T, Sakamoto S, Kamiyama M, Tanaka N, Mitsuzuka K, Kato T, Narita S, Yasumoto H, Teraoka S, Kato M, Osawa T, Nagumo Y, Matsumoto H, Enokida H, Sugiyama T, Kuroiwa K, Inoue T, Sugimoto M, Mizowaki T, Kamoto T, Nishiyama H, Eto M; Japanese Urological Oncology Group: Novel metastatic burden-stratified risk model in de novo metastatic hormone-sensitive prostate cancer. Cancer Sci. 112(9); 3616-3626: 2021
Kubo T, Sugawara T, Shinkawa T, Kurisu T, Kouzen N, Tanaka T, Fukuta F, Yamasaki K, Sugita S, Matsuo K, Morita R, Hirohashi Y, Tsukahara T, Kanaseki T, Hasegawa T, Masumori N, Torigoe T: Fatal fulminant hepatitis induced by combined ipilimumab and nivolumab therapy despite favorable histologic response and confirmed by autopsy in a patient with clear cell renal cell carcinoma. Immunol Med. 44(2); 136-141: 2021
Kyoda Y, Okada M, Kato R, Matsuki M, Ito N, Takahashi A, Tanuma Y, Tachiki H, Fukuta F, Hashimoto K, Kobayashi K, Tanaka T, Masumori N: Does cognitive behavioral therapy using a self-check sheet improve night-time frequency in patients with nocturia? Results of a multicenter randomized controlled trial , Int J Urol. doi: 10.1111/iju.14489: 2021
Tabata H, Sasaki M, Kataoka-Sasaki Y, Shinkai N, Ichihara K, Masumori N, Kocsis JD, Honmou O: Possible role of intravenous administration of mesenchymal stem cells to alleviate interstitial cystitis/bladder pain syndrome in a Toll like receptor 7 agonist induced experimental animal model in rat. BMC Urol. 21(1); 156: 2021
Tachikawa K, Kyoda Y, Fukuta F, Kobayashi K, Masumori N：Efficacy of vibegron in patients with overactive bladder : Multicenter prospective study of real-world clinical practice in Japan, SCCOP study 19-01, Low Urin Tract Symptoms.28; doi: 10.1111/luts.12417: 2021
Yoshimura N, Homma Y, Tomoe H, Otsuka A, Kitta T, Masumori N, Akiyama Y, Niimi A, Mitsui T, Nanri M, Namima T, Takei M, Yamaguchi A, Sekiguchi Y, Kajiwara M, Kobayashi S, Ameda K, Ohashi Y, Sakamoto S, Muraki O, Shishido T, Kageyama S, Kokura K, Okazoe H, Yamanishi T, Watanabe T, Uno T, Ohinata A, Ueda T. Efficacy and safety of intravesical instillation of KRP-116D (50% dimethyl sulfoxide solution) for interstitial cystitis/bladder pain syndrome in Japanese patients: A multicenter, randomized, double-blind, placebo-controlled, clinical study. Int J Urol. 28(5); 545-553: 2021
Yoshida M, Takeda M, Gotoh M, Yokoyama O, Kakizaki H, Takahashi S, Masumori N, Nagai S, Minemura K. Cardiovascular safety of vibegron, a new β3-adrenoceptor agonist, in older patients with overactive bladder: Post-hoc analysis of a randomized, placebo-controlled, double-blind comparative phase 3 study. Neurourol Urodyn. 40(6); 1651-1660: 2021
MaehanaT, Ichihara K, Takahashi S, Takahashi Y, Hashimoto K, Tanaka T, Masumori N: Significance of urinary liver-type fatty acid-binding protein in patients with normal renal function after undergoing intestinal urinary diversion: a preliminary study. Clin Exp Nephrol. 25(10); 1151-1157: 2021
Kirisawa T, Ichihara K, Sakai Y, Morooka D, Iyoki T, Masumori N : Physical and Psychological Effects of Gender-Affirming Hormonal Treatment Using Intramuscular Testosterone Enanthate in Japanese Transgender Men, Sex Med.; 9:100306: 2021
Masumori N, Baba T, Abe T and Niw K: What is the most anticipated change induced by treatment using Gender-affirming hormones in individuals with gender incongruence? Int J Urol. 28; 526-529: 2021
Saito N, Nagahara D, Ichihara K, Masumori N, Miura T, Takahashi S: Gender-affirming hormone treatment causes changes in gender phenotype in a 12-lead electrocardiogram. Heart Rhythm. 18(7);1203-1209 : 2021
舛森直哉：性同一性障害に対する手術、陰茎?陰嚢?アンドロロジーの手術、Urologic Surgery Next8
Nishida S, Nagaishi K, Motoya M, Kumagai A, Terada N, Kasuga A, Kubota N, Iesato K, Kimizuka M, Miyajima S, Koyama M, Ohnishi H, Narimatsu E, Masumori N, Tsuchihashi K, Tsukamoto T, Tsuji Y. Dilemma of physician-mothers faced with an increased home burden and clinical duties in the hospital during the COVID-19 pandemic. PLoS One 16 (6); e0253646: 2021
Muranaka T, Masumori N. Bilateral ureteral reconstruction using appendicular interposition combined with Wallace anastomosis following stenosis after radical cystectomy and ileal neobladder construction. Asian J Urol. 8 (2); 246-247: 2021
